NYU Child Study Center
New York, 10016, United States
NCT Number: NCT01315327
This study examines the safety and efficacy of omega-3 fatty acids (fish oil) for the treatment of Tourette's Disorder.
Looking for future studies?
Notify Me6 year–18 year
All sexes
Interventional
Not applicable
New York, 10016, United States
This is a 20-week, double-blind, placebo (olive oil) controlled study examining supplemental fish oil in the treatment of tic and OCD symptoms.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Omega-3 fatty acids (derived from fish oil)
Placebo
Time frame: Baseline and then weekly for 20 weeks
This assessment captures tic type and frequency as well as intensity and complexity, and impairment due to tics.
Time frame: Baseline and then weekly for 20 weeks
Assesses type, frequency, and impairment of obsessions and compulsions
NYU Langone Health
Other
A Double-Blind, Placebo-Controlled Study of Omega-3 Fatty Acids in Children and Adolescents With Tourette's Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03508245
Basal Ganglia Diseases, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT03916055
Basal Ganglia Diseases, Brain Diseases
Stockholm, Sweden
View Trial DetailsNCT02864589
Basal Ganglia Diseases, Brain Diseases
Stockholm, Sweden
View Trial DetailsNCT02413216
Basal Ganglia Diseases, Brain Diseases
Salt Lake City, Utah, United States
View Trial Details